Riboflavin (B2) and niacin (B9) were predicted to be synthesized by more than half of the gut microbiota members studied 34
Eli Lilly is the maker of the blockbuster GLP-1 drug tirzepatide, approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea
However, the inhibitory potency of these natural compounds remains orders of magnitude below pharmaceutical DPP-4 inhibitors
[PMID: 12920348] PubMed record related to this compound for laboratory literature review
In being so concerned about finding revenue opportunities in this GLP-1 space, what other therapies, conditions, and patients arent maybe getting equivalent sorts of interest, money, and research time invested in them as they otherwise might have? How GLP-1s are changing healthcare dynamics The popularity of GLP-1 drugs is altering the traditional doctor-patient relationship
Taken once daily, it works by increasing insulin secretion when glucose levels rise, reducing glucagon production, slowing gastric emptying, and helping regulate appetite